CHARLOTTE, N.C., Sept. 12, 2017 -- SPX Corporation (NYSE:SPXC) today announced the appointment of Franklin McClelland as Vice President, Business Development and Strategy.
Mr. McClelland joins SPX Corporation from Allegion Plc where he was Vice President, Strategy and Business Development. During his time at Allegion, he was instrumental in the completion of over 15 transactions which helped transform the organizational portfolio into a network of market-leading brands. He brings an extensive skillset in mergers & acquisitions and strategy acquired through prior experience including roles at Ingersoll Rand (Allegion’s former parent company) and The Boston Consulting Group. Franklin holds a BA from Williams College and an MBA from the Kellogg School of Management at Northwestern University.
“We are pleased to welcome Franklin to lead our business development and strategy efforts,” said Gene Lowe, SPX's President and Chief Executive Officer. “With his extensive experience in corporate strategy and M&A, Franklin will play a critical role as we execute on our organic and inorganic growth initiatives.”
About SPX Corporation: SPX Corporation is a supplier of highly engineered products and technologies, holding leadership positions in the HVAC, detection and measurement, and engineered solutions markets. Based in Charlotte, North Carolina, SPX Corporation had approximately $1.5 billion in annual revenue in 2016 and more than 5,000 employees in about 15 countries. SPX Corporation is listed on the New York Stock Exchange under the ticker symbol “SPXC.” For more information, please visit www.spx.com.
Investor and Media Contacts:
Paul Clegg, VP, Investor Relations and Communications
Phone: 980-474-3806
E-mail: [email protected]
Pat Uotila, Manager, Investor Relations
Phone: 980-474-3806
E-mail: [email protected]


Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
Seatrium Reaches $475 Million Settlement With Maersk Over Offshore Wind Vessel Project
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
Italy Fines Apple €98.6 Million Over App Store Dominance
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions 



